Modulation of Wnt signalling in ocular disorders
Summary
The European Patent Office published patent application EP3924381A1 for Surrozen Operating, Inc., covering Wnt signaling modulators and their use in treating ocular disorders. The patent application includes claims on therapeutic compositions and methods for eye diseases. This IP filing affects companies developing treatments for ophthalmic conditions involving Wnt pathway modulation.
What changed
The European Patent Office published patent application EP3924381A1 titled 'Modulation of Wnt signalling in ocular disorders' filed by Surrozen Operating, Inc. The application covers methods and compositions for modulating Wnt signaling to treat eye diseases, including claims on therapeutic proteins and antibodies targeting Wnt pathway components.
For pharmaceutical and biotech companies active in ophthalmology drug development, this patent establishes intellectual property protection that may restrict freedom to operate in the Wnt-based ocular therapeutics space. Companies should conduct freedom-to-operate analyses and consider potential licensing discussions with Surrozen.
What to do next
- Assess freedom to operate for Wnt pathway ocular disease programs
- Review patent claims for potential licensing opportunities
- Monitor for related patent filings in ophthalmology space
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS
Publication EP3924381A1 Kind: A1 Apr 01, 2026
Applicants
Surrozen Operating, Inc.
Inventors
LI, Yang, TU, Shengjiang, LEE, Sungjin, YEH, Wen-Chen
IPC Classifications
C07K 16/18 20060101AFI20230622BHEP C07K 16/28 20060101ALI20230622BHEP A61P 27/02 20060101ALI20230622BHEP C12N 15/11 20060101ALI20230622BHEP A61K 38/17 20060101ALI20230622BHEP C07K 14/435 20060101ALI20230622BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.